Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2025-12-11 00:00:00 ET · period of report 2025-12-09 · accession 0001411984-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-11 | 2025-12-09 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $701.51 | -2,552 | 21.7K | -11% | -$1.79M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-09 | F | D | 2,552 | $701.51 | 21,673 | D | — | — |